LumiraDx Limited Warrant (LMDXW)

LMDXW was delisted on the 8th of January, 2024.

• Market cap: $1.31M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.

Employees: 1,210